Similar to This
Previous
Is brain inflammation at the core of cognitive decline? What latest research says
medicalnewstoday.com/articles/brain-health-inflammation-alzheimers-dementia-studies-hsv1-nsaid
Alzheimer's expert reveals how to reduce dementia risk — when to eat breakfast, what goes in coffee
nypost.com/2025/01/17/health/alzheimers-expert-reveals-7-easy-ways-to-reduce-dementia-risk/

Study reveals how pregnancy rewires a woman's brain for at least two years: A new study has shown that just like the body, a pregnant woman's brain ...
standardmedia.co.ke/health/health-science/article/2001503661/study-reveals-how-pregnancy-rewires-a-womans-brain-for-at-least-two-years
Lecanemab: First drug to slow Alzheimer’s too costly for NHS: Health assessment body NICE says the benefits “are too small to justify the costs”.
bbc.com/news/articles/c75nry66y52o

Key FactsLecanemab: Costly Breakthrough in Alzheimer Treatment
Aug 22, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: bbc.com
Summary created with AI assistance · Source: bbc.com
- Lecanemab, the first drug shown to slow early-stage Alzheimer's, will not be available through the NHS in England as NICE deems its benefits insufficient to justify the costs, despite receiving approval from the MHRA for private prescriptions.
- In clinical trials, Lecanemab demonstrated a 25% reduction in cognitive decline over 18 months for early-stage Alzheimer's patients. However, NICE highlighted the high costs associated with treatment, including intensive monitoring and frequent hospital visits.
- Administered bi-weekly as an intravenous infusion, Lecanemab targets amyloid protein accumulation in the brain. Concerns arose regarding side effects, including small brain bleeds, leading to some patients requiring hospitalization.
- Though the benefits of Lecanemab may seem modest, it represents a significant advancement in Alzheimer's research. Health organizations expressed concern for nearly one million dementia patients facing uncertainty, while the EMA rejected its license due to serious risk concerns.
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
cnbc.com/2024/07/30/novo-nordisk-glp-1-liraglutide-may-slow-alzheimers-progression.html

Could pomegranates help aid memory and ease Alzheimer’s symptoms?: A compound found in pomegranates that is available in pill form could help improve memory and ...
medicalnewstoday.com/articles/compound-in-pomegranate-may-aid-memory-in-alzheimers
Childhood and midlife stress could increase risk of developing Alzheimer’s : Childhood is a time of significant brain development while midlife is when ...
scroll.in/article/1067867/childhood-and-midlife-stress-could-increase-risk-of-developing-alzheimers

Youth and midlife stress events linked to increased dementia risk in later life, study finds
wionews.com/science/youth-and-midlife-stressors-linked-to-increased-dementia-risk-in-later-life-study-finds-721492

Study flags diabetes, alcohol and pollution as risk factors for dementia: How to modify these triggers and protect brain health
indianexpress.com/article/health-wellness/diabetes-alcohol-pollution-risk-factors-dementia-brain-health-9258226/

6 of the most important vitamins and minerals for brain health (and how to get more of them)
stylist.co.uk/fitness-health/nutrition/best-vitamins-minerals-for-brain-health/874108

The case for a tuberculosis vaccine to prevent dementia: The BCG vaccine has been in use since 1921. Now two new papers survey the vaccine and explain how it may ...
haaretz.com/science-and-health/2024-02-26/ty-article/the-case-for-a-tuberculosis-vaccine-to-prevent-dementia/0000018d-e05a-d03b-a7cd-e3dab1150000
Innovative therapy delivery system may help fight brain inflammation: An innovative nanoparticle delivery system could in the future help treat brain ...
medicalnewstoday.com/articles/innovative-therapy-delivery-system-may-help-fight-brain-inflammation
Researchers return to Alzheimer's vaccines, buoyed by recent drug success: Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have ...
reuters.com/business/healthcare-pharmaceuticals/researchers-return-alzheimers-vaccines-buoyed-by-recent-drug-success-2023-11-20/
/cloudfront-us-east-2.images.arcpublishing.com/reuters/44DLHLDT6NLKRBD4B3LGYE2GVM.jpg)
Hidden belly fat linked to brain inflammation and dementia, study finds: Fat that surrounds the organs deep inside the abdomen contributes to brain inflammation ...
cnn.com/2023/11/20/health/belly-fat-alzheimers-wellness/

Stored belly fat in 40s, 50s maybe a sign of Alzheimer’s disease: Study: A study underscores how visceral fat, deeply nestled within, can significantly impact ...
financialexpress.com/life/stored-belly-fat-in-40s-50s-maybe-a-sign-of-alzheimers-disease-study-bkg-3314275/

Flu shots may protect against the risk of Alzheimer’s, related dementias: Some studies have shown that vaccinated individuals appear less likely than the ...
washingtonpost.com/wellness/2023/10/25/flu-shots-alzheimers-dementias-vaccinations-infectious-diseases/

Scientists discover how brain cells die in Alzheimer’s: The findings, which had been a mystery for decades, give new ideas for treating the disease.
bbc.com/news/health-66816268

Scientists claim new vaccine could reduce effects of Alzheimer's: The vaccine, which has been developed in Japan, hasn't yet been tested on humans
chroniclelive.co.uk/news/health/vaccine-reduce-prevent-alzheimers-japan-27425397

Critical research on the causes of Alzheimer’s may have been falsified: Scientists could have been led down blind alleys for more than a decade
economist.com/science-and-technology/2022/07/23/critical-research-on-the-causes-of-alzheimers-may-have-been-falsified

Next
